EGenesis Company
EGenesis focuses on leveraging genome editing technology to deliver safe and effective human transplantable cells, tissues, and organs.
Investors
.jpeg)
Technology:
Bioengineering
Industry:
Geroscience, Private
Headquarters:
Cambridge, Massachusetts, United States
Founded Date:
2014-01-01
Employees Number:
1-10
Funding Status:
Late Stage Venture
Investors Number:
28
Total Funding:
265000000
Estimated Revenue:
$1M to $10M
Last Funding Date:
2021-03-02
Last Funding Type:
Series C
Register and Claim Ownership